Nunzia Pharmaceutical (NUNZ) 10-K 2021 FY Annual report

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, as the President, Chief Executive Officer and the Chief Financial Officer of Nunzia Pharmaceutical Company, respectively, certifies that, to the best of their knowledge and belief, the Annual Report on Form 10-K for the years ended December 31, 2021 and 2020 that accompanies this certification fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of Nunzia Pharmaceutical Company at the dates and for the periods indicated. The foregoing certification is made pursuant to 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350) and shall not be relied upon for any other purpose.

Date: April 15, 2022	By: /s/ Sara Gonzales
	Name: Sara Gonzales
	Title: Chief Executive Officer and Director
Date: April 15, 2022	By: /s/ Michael Mitsunaga
	Name: Michael Mitsunaga
	Title: President, Chief Financial Officer, Treasurer, Secretary and Director